Sorry, but you are 100% wrong about the ability to scale in the US. I have been in Senior Management both in operations and IT for sales and customer support for over 25 years.
It was crystal clear that Dexcom’s plan was to kill these jobs in the US from approximately three years ago. They hired substandard managers over these areas, and they did not take into account the 21st century workplace which is focused on work from home for skilled customer support and inside sales. As an example, in the Phoenix area there are over 30,000 work from home sales and support employees. There is a substantial cost of maintaining these workers in company owned or leased real estate.
Dexcom’s sole interest is in enriching their Senior Management. Obviously in the short-term, this helps shareholders. However in the long run, this sets the company up for either being acquired or being knocked off by better managed competition. I don’t believe either case bodes well for Dexcom’s customers.
Again, I have zero interest in doing any business with companies who cannot be competitive with American workers. The only reason that manufacturing isn’t going to be sent to some backwater Chinese town is due to regulation. It will be interesting to see if their legal liabilities increase and regulatory oversight kicks in due to offshoring technical support. I suppose that their executive team believes that won’t happen before they get their payouts, cut bait and run.